A detailed history of Lgt Financial Advisors LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 83 shares of AMPH stock, worth $3,176. This represents 0.01% of its overall portfolio holdings.

Number of Shares
83
Previous 83 -0.0%
Holding current value
$3,176
Previous $3.32 Million 21.33%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$38.65 - $43.48 $1,932 - $2,174
-50 Reduced 37.59%
83 $3.32 Million
Q3 2023

Nov 01, 2023

BUY
$45.51 - $65.0 $6,052 - $8,645
133 New
133 $6.12 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.88B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.